Review Article
Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females
Table 7
Efficacy in less than 3-doses [68].
| ||||||||||||||||||||||||
One-year persistence was defined as two positive tests for the same HPV type in visits 10+ months apart in women negative at enrollment for that HPV type with no intervening negatives and whose infection occurred after randomization. TVC* means total vaccinated cohort of women who were HPV 16/18 DNA-negative at baseline regardless of serostatus and regardless of entry cytology and who had at least one follow-up datum. Attack rate of HPV 16/18 infection in the control arm was consistently 4.5–5/100 women over the study. |